<DOC>
	<DOCNO>NCT01534910</DOCNO>
	<brief_summary>The investigator assess effect Aged Garlic Extract coronary artery . The investigator enroll patient double blind study , half patient receive placebo , patient undergo series test plaque ( CT scan heart , carotid ultrasound ) follow patient drug placebo repeat test blood work end one year . The investigator assess age garlic extract add benefit plaque coronary neck artery . The investigator also assess effect age garlic extract marker inflammation . Patients receive free drug , free testing compensate , learn heart neck artery . successful , patient use drug benefit health . The harm include radiation CT scan medication , mild side effect .</brief_summary>
	<brief_title>Effect Aged Garlic Extract Atherosclerosis</brief_title>
	<detailed_description>The investigator assess effect Aged Garlic Extract coronary artery . The investigator enroll patient double blind study , half patient receive placebo , patient undergo series test plaque ( CT scan heart , carotid ultrasound ) follow patient drug placebo repeat test blood work end one year . The investigator assess age garlic extract add benefit plaque coronary neck artery . The investigator also assess effect age garlic extract marker inflammation . Patients receive free drug , free testing compensate , learn heart neck artery . successful , patient use drug benefit health . The harm include radiation CT scan medication , mild side effect . The study perform advance CT angiography baseline follow along carotid intimal medium thickness testing , see plaque slow Aged Garlic Extract</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Inclusion Criteria Age 4065 year Framingham risk score 620 % , least 2 component metabolic syndrome define ATP III Clinical Identification Metabolic Syndrome ( include impair fast glucose &gt; 110 mg/dl , treat hypertension SBP &gt; 130 DBP &gt; 85 mm Hg , plasma triglyceride &gt; 150 mg/dl , HDL cholesterol &lt; 35 mg/dl men &lt; 40 mg/dl woman , abdominal obesity define waist &gt; 40 men , &gt; 35 woman ) Subjects must provide write informed consent scope nature investigation explain Subjects stable concomitant medication least 26 week prior randomization Calcium Score &gt; 20 baseline Subjects agree refrain antiglycemic agent Exclusion Criteria A contraindication AGE include : know hypersensitivity drug . Any unstable medical , psychiatric substance abuse disorder opinion investigator principal investigator likely affect subject 's ability complete study precludes subject 's participation study Weight excess 300 pound Bleeding disorder History know coronary artery disease , myocardial infarction , stroke lifethreatening arrhythmia within prior six month NYHA Class II IV heart failure History malignancy within last 5 year ( skin cancer ) evidence active cancer would require concomitant cancer chemotherapy Serum creatinine &gt; 1.4 mg/dl Diabetes Mellitus Triglycerides &gt; 400 visit 1 Drug alcohol abuse , current intake 14 standard drink per week Concurrent enrollment another placebocontrolled trial Partial ileal bypass know gastrointestinal disease limit drug absorption Current diabetes intake antidiabetic prohibit drug Current tobacco use Current use anticoagulant ( except antiplatelet agent ) Renal failure History hypertensive encephalopathy cerebrovascular accident Hematological biochemical value screen outside reference range consider clinically significant opinion investigator PI</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>garlic</keyword>
	<keyword>ct angiography</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>carotid IMT</keyword>
</DOC>